Sort
130,381 grants matching “hiv”
Advanced generation infection-proof anti-HIV CAR-T with YY1 RNAi to block T cell exhaustion in NHP model
$1,000,000Richard P Junghans · It Bio, Llc · R44 · FY2022 · AI
IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES
$1,000,000Jean William Pape · Gheskio Center · U2G · FY2012 · GH
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · SB1 · FY2018 · AI
A first-in-class product for the clearance of high-risk human papillomaviruses
$1,000,000Andrea Ries Thurman · Dare Bioscience, Inc. · R44 · FY2025 · AI
New Class of Bright, Sharp, Tunable Near-Infrared Fluorophores for Flow Cytometry
$1,000,000Christopher J Macnevin · Nirvana Sciences, Inc. · R44 · FY2019 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · SB1 · FY2023 · AI
Regeneration of Epidermal Nerves in Human Diabetic Neuropathy
$1,000,000Angela Hansen · Winsantor, Inc. · R44 · FY2019 · DK
Continuing Development of PPCM Vaginal Contraceptive Microbicide
$1,000,000Mary B Weitzel · Yaso Therapeutics Inc · R44 · FY2013 · AI
A single antiviral to treat multiple opportunistic infections
$1,000,000Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2020 · AI
Development of Broad Spectrum Host Oriented Therapeutic Antibodies against Influe
$1,000,000Wu-Bo Li · Functional Genetics, Inc. · R44 · FY2011 · AI
IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES (COUNSELING AND TESTING, PR
$1,000,000Jean William Pape · Gheskio Center · U2G · FY2012 · GH
Glycoengineering eCD4-Ig
$1,000,000Michael David Alpert · Emmune, Inc · R44 · FY2023 · AI
BLDG HLTH DEPT CPCTY FOR HIGH IMPCT HIV PREV THRU TECH COOP
$1,000,000Matthew R Golden · University Of Washington · U65 · FY2014 · PS
GH11-11112: IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES
$1,000,000Jean William Pape · Gheskio Center · U2G · FY2013 · GH
Advanced PML antiviral
$1,000,000Milton H. Werner · Inhibikase Therapeutics · R44 · FY2017 · AI
HIV pathogenesis, prevention and treatment in the Andes
$1,000,000Asociacion Civil Impacta Salud Y Educacn · U19 · FY2004 · AI
A Novel Test to Measure Latent Virus in HIV-1 Infected Patients
$1,000,000Gregory Michael Laird · Accelevir Diagnostics, Llc · R44 · FY2019 · AI
Genomic and environmental risk factors for cardiometabolic disease in Africans
$1,000,000Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2016 · HG
Early and accurate diagnosis of pulmonary and extrapulmonary tuberculosis in all patient groups using a circulating pathogen-derived antigen
$1,000,000Thomas W Tombler · Nanopin Technologies, Inc. · R44 · FY2022 · AI
PHIDISA
$1,000,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
GH11-1150, S. AFRICA: PROVISION OF MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL
$1,000,000Scott Billy · Population Services International · U2G · FY2015 · GH
STRENGTHENING PREVENTION TO EFFECTIVELY REDUCE HIV INCIDENCE THROUGH MOBILE HCT
$1,000,000Bruce Forgrieve · Shout It Now · U2G · FY2011 · GH
Programatic-Strengthening Medical Education for Improved Health Outcomes in Kenya
$1,000,000James Njogu Kiarie · University Of Nairobi · R24 · FY2010 · TW
PIPP Phase I: Advancing Environmental Surveillance for Pandemic Prediction in Remote and Resource Poor Settings
$1,000,000Scott Berry · University Of Kentucky Research Foundation · · FY2022 · CSE
Safety and Efficacy Evaluations of Topical Microbicide/Biomedical Prevention Products in the Repeat Low-Dose Macaque SlV /SHIV Infection Model
$1,000,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2016 · AI